AI-Assisted Non-Contrast CT for Multi-Cancer Screening

Recruiting now · Not applicable

Conditions studied: Lung Cancers, Liver Cancer, Gastric Cancers, Colorectal, Cancer, Esophageal Cancer, Pancreatic Cancer, Breast Cancer

In brief

Cancer poses a major public health challenge in China. Early detection can improve treatment outcomes and survival rates. In this study, we will conduct a large-scale, prospective, multi-center cohort study to evaluate the utility of AI-assisted non-contrast CT for multi-cancer screening. The study aims to enroll 1 million asymptomatic participants undergoing routine health examinations, using an AI imaging model based on non-contrast CT to detect seven cancers such as lung, liver, gastric, colorectal, esophageal, pancreatic, and breast cancers. Positive cases will be required to be referred to Shanghai Changhai Hospital for further imaging and care based on National Comprehensive Cancer Network (NCCN) and American College of Radiology (ACR) guidelines. The goal is to assess the AI model's diagnostic performance for seven cancer types, especially for early-stage, resectable tumors.

Key facts

Study ID
NCT06632886
Run by
Guo ShiWei
People needed
1000000
Starts
2024-10-07
Expected to finish
2027-10-07
Last updated by the study team
2024-10-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.